Taken together, our data indicate that EYA4 deficiency in HCC pathogenesis was associated with the hyperactivated NF-κB signaling pathway and up-regulated RAP1 expression, which further contributed to the aggressiveness of malignant liver tumors. The gene discussed is RAP1A; the disease is cancer.